HLVX

HLVX

USD

HilleVax Inc. Common Stock

$2.090-0.010 (-0.476%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Aucune donnée graphique disponible

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$2.100

Haut

$2.090

Bas

$2.090

Volume

N/A

Fondamentaux de l'Entreprise

Capitalisation Boursière

104.8M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.69M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $1.34Actuel $2.090Haut $2.17

Actualités Connexes

PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Voir plus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders
PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX)

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

Voir plus
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX)
GlobeNewswire

HilleVax Reports Second Quarter 2025 Financial Results

BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the

Voir plus
HilleVax Reports Second Quarter 2025 Financial Results
PR Newswire

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.

Rowley Law PLLC is investigating potential securities law violations by HilleVax, Inc. (NASDAQ: HLVX) and its board of directors concerning the...

Voir plus
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.
PR Newswire

Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders

The Ademi Firm is investigating HilleVax (NASDAQ: HLVX) for possible breaches of fiduciary duty and other violations of law in its transaction with...

Voir plus
Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders
GlobeNewswire

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX) and XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ:XOMA) announced today they have entered

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.